Home › CeloNova Announces Accelerated IDE Trial Enrollment Completion For Its COBRA PzF Coronary Stent System
 

Keywords :   


CeloNova Announces Accelerated IDE Trial Enrollment Completion For Its COBRA PzF Coronary Stent System

2015-02-20 03:50:57| surfacefinishing News Articles

CeloNova BioSciences, Inc. announced completion of patient enrollment in the global, multi-center IDE trial for its COBRA PzF stent. Completed enrollment was ahead of schedule and supports submission for FDA approval of the novel COBRA PzF stent with its advanced, nano-thin coating of Polyzene-F polymer

Tags: system trial completion ide

Category:Materials

Latest from this category

All news
»
06.10Hurricane Milton Public Advisory Number 5A
06.10Summary for Hurricane Milton (AT4/AL142024)
06.10Atlantic Tropical Weather Outlook
06.10Eastern North Pacific Tropical Weather Outlook
06.10Glatfelter Develops Biobased Espresso Lid Material
06.10Tropical Storm Milton Potential Storm Surge Flooding Map
06.10Tropical Storm Milton Probabilistic Storm Surge Graphics
06.10Firms urge mayor to rethink congestion charge plan
More »